Connect with us

Business

Anthropic CEO Dario Amodei escalates war of words with Jensen Huang, calling out ‘outrageous lie’ and getting emotional about father’s death

Published

on



The doomers versus the optimists. The techno-optimists and the accelerationists. The Nvidia camp and the Anthropic camp. And then, of course, there’s OpenAI, which opened the Pandora’s Box of artificial intelligence in the first place.

The AI space is driven by debates about whether it’s a doomsday technology or the gateway to a world of future abundance, or even whether it’s a throwback to the dotcom bubble of the early 2000s. Anthropic CEO Dario Amodei has been outspoken about AI’s risks, even famously predicting it would wipe out half of all white-collar jobs, a much gloomier outlook than the optimism offered by OpenAI’s Sam Altman or Nvidia’s Jensen Huang in the past. But Amodei has rarely laid it all out in the way he just did on tech journalist Alex Kantrowitz’s Big Technology podcast on July 30.

In a candid and emotionally charged interview, Amodei escalated his war of words with Nvidia CEO Jensen Huang, vehemently denying accusations that he is seeking to control the AI industry and expressing profound anger at being labeled a “doomer.” Amodei’s impassioned defense was rooted in a deeply personal revelation about his father’s death, which he says fuels his urgent pursuit of beneficial AI while simultaneously driving his warnings about its risks, including his belief in strong regulation.

Amodei directly confronted the criticism, stating, “I get very angry when people call me a doomer … When someone’s like, ‘This guy’s a doomer. He wants to slow things down.’” He dismissed the notion, attributed to figures like Jensen Huang, that “Dario thinks he’s the only one who can build this safely and therefore wants to control the entire industry” as an “outrageous lie. That’s the most outrageous lie I’ve ever heard.” He insisted that he’s never said anything like that.

His strong reaction, Amodei explained, stems from a profound personal experience: his father’s death in 2006 from an illness that saw its cure rate jump from 50% to roughly 95% just three or four years later. This tragic event instilled in him a deep understanding of “the urgency of solving the relevant problems” and a powerful “humanistic sense of the benefit of this technology.” He views AI as the only means to tackle complex issues like those in biology, which he felt were “beyond human scale.” As he continued, he explained how he’s actually the one who’s really optimistic about AI, despite his own doomsday warnings about its future impact.

Who’s the real optimist?

Amodei insisted that he appreciates AI’s benefits more than those who call themselves optimists. “I feel in fact that I and Anthropic have often been able to do a better job of articulating the benefits of AI than some of the people who call themselves optimists or accelerationists,” he asserted.

In bringing up “optimist” and “accelerationist,” Amodei was referring to two camps, even movements, in Silicon Valley, with venture-capital billionaire Marc Andreessen close to the center of each. The Andreessen Horowitz co-founder has embraced both, issuing a “techno-optimist manifesto” in 2023 and often tweeting “e/acc,” short for effective accelerationism.

Both terms stretch back to roughly the mid-20th century, with techno-optimism appearing shortly after World War II and accelerationism appearing in the science-fiction of Roger Zelazny in his classic 1967 novel “Lord of Light.” As Andreessen helped popularize and mainstream these beliefs, they roughly add up to an overarching belief that technology can solve all of humanity’s problems. Amodei’s remarks to Kantrowitz revealed much in common with these beliefs, with Amodei declaring that he feels obligated to warn about the risks inherent with AI, “because we can have such a good world if we get everything right.”

Amodei claimed he’s “one of the most bullish about AI capabilities improving very fast,” saying he’s repeatedly stressed how AI progress is exponential in nature, where models rapidly improve with more compute, data, and training. This rapid advancement means issues such as national security and economic impacts are drawing very close, in his opinion. His urgency has increased because he is “concerned that the risks of AI are getting closer and closer” and he doesn’t see that the ability to handle risk isn’t keeping up with the speed of technological advance.

To mitigate these risks, Amodei champions regulations and “responsible scaling policies” and advocates for a “race to the top,” where companies compete to build safer systems, rather than a “race to the bottom,” with people and companies competing to release products as quickly as possible, without minding the risks. Anthropic was the first to publish such a responsible scaling policy, he noted, aiming to set an example and encourage others to follow suit. He openly shares Anthropic’s safety research, including interpretability work and constitutional AI, seeing them as a public good.

Amodei addressed the debate about “open source,” as championed by Nvidia and Jensen Huang. It’s a “red herring,” Amodei insisted, because large language models are fundamentally opaque, so there can be no such thing as open-source development of AI technology as currently constructed.

An Nvidia spokesperson, who provided a similar statement to Kantrowitz, told Fortune that the company supports “safe, responsible, and transparent AI.” Nvidia said thousands of startups and developers in its ecosystem and the open-source community are enhancing safety. The company then criticized Amodei’s stance calling for increased AI regulation: “Lobbying for regulatory capture against open source will only stifle innovation, make AI less safe and secure, and less democratic. That’s not a ‘race to the top’ or the way for America to win.” 

Anthropic reiterated its statement that it “stands by its recently filed public submission in support of strong and balanced export controls that help secure America’s lead in infrastructure development and ensure that the values of freedom and democracy shape the future of AI.” The company previously told Fortune in a statement that “Dario has never claimed that ‘only Anthropic’ can build safe and powerful AI. As the public record will show, Dario has advocated for a national transparency standard for AI developers (including Anthropic) so the public and policymakers are aware of the models’ capabilities and risks and can prepare accordingly.”

Kantrowitz also brought up Amodei’s departure from OpenAI to found Anthropic, years before the drama that saw Sam Altman fired by his board over ethical concerns, with several chaotic days unfolding before Altman’s return.

Amodei did not mention Altman directly, but said his decision to co-found Anthropic was spurred by a perceived lack of sincerity and trustworthiness at rival companies regarding their stated missions. He stressed that for safety efforts to succeed, “the leaders of the company … have to be trustworthy people, they have to be people whose motivations are sincere.” He continued, “if you’re working for someone whose motivations are not sincere who’s not an honest person who does not truly want to make the world better, it’s not going to work you’re just contributing to something bad.”

Amodei also expressed frustration with both extremes in the AI debate. He labeled arguments from certain “doomers” that AI cannot be built safely as “nonsense,” calling such positions “intellectually and morally unserious.” He called for more thoughtfulness, honesty, and “more people willing to go against their interest.”

For this story, Fortune used generative AI to help with an initial draft. An editor verified the accuracy of the information before publishing. 



Source link

Continue Reading

Business

Trump wants more health savings accounts. A catch: they can’t pay insurance premiums

Published

on



With the tax-free money in a health savings account, a person can pay for eyeglasses or medical exams, as well as a $1,700 baby bassinet or a $300 online parenting workshop.

Those same dollars can’t be used, though, to pay for most baby formulas, toothbrushes — or insurance premiums.

President Donald Trump and some Republicans are pitching the accounts as an alternative to expiring enhanced federal subsidies that have lowered insurance premium payments for most Americans with Affordable Care Act coverage. But legal limits on how HSAs can and can’t be used are prompting doubts that expanding their use would benefit the predominantly low-income people who rely on ACA plans.

The Republican proposals come on the heels of a White House-led change to extend HSA eligibility to more ACA enrollees. One group that would almost certainly benefit: a slew of companies selling expensive wellness items that can be purchased with tax-free dollars from the accounts.

There is also deep skepticism, even among conservatives who support the proposals, that the federal government can pull off such a major policy shift in just a few weeks. The enhanced ACA subsidies expire at the end of the year, and Republicans are still debating among themselves whether to simply extend them.

“The plans have been designed. The premiums have been set. Many people have already enrolled and made their selections,” Douglas Holtz-Eakin, the president of the American Action Forum, a conservative think tank, warned senators on Nov. 19. “There’s very little that this Congress can do to change the outlook.”

Cassidy’s Plan

With health savings accounts, people who pay high out-of-pocket costs for health insurance are able to set aside money, without paying taxes, for medical expenses.

For decades, Republicans have promoted these accounts as a way for people to save money for major or emergent medical expenses without spending more federal tax dollars on health care.

The latest GOP proposals would build on a change included in Republicans’ One Big Beautiful Bill Act, which makes millions more ACA enrollees eligible for health savings accounts. Starting Jan. 1, those enrolled in Obamacare’s cheapest coverage may open and contribute to HSAs.

Now Republicans are making the case that, in lieu of the pandemic-era enhanced ACA subsidies, patients would be better off being given money to cover some health costs — specifically through deposits to HSAs.

The White House has yet to release a formal proposal, though early reports suggested it could include HSA contributions as well as temporary, more restrictive premium subsidies.

Sen. Bill Cassidy — a Louisiana Republican who chairs the Senate Health, Education, Labor, and Pensions Committee and is facing a potentially tough reelection fight next year — has proposed loading HSAs with federal dollars sent directly to some ACA enrollees.

“The American people want something to pass, so let’s find something to pass,” Cassidy said on Dec. 3, pitching his plan for HSAs again. “Let’s give power to the patient, not profit to the insurance company.”

He has promised a deal can be struck in time for 2026 coverage.

Democrats, whose support Republicans will likely need to pass any health care measure, have widely panned the GOP’s ideas. They are calling instead for an extension of the enhanced subsidies to control premium costs for most of the nearly 24 million Americans enrolled in the ACA marketplace, a larger pool than the 7.3 million people the Trump administration estimates soon will be eligible for HSAs.

HSAs “can be a useful tool for very wealthy people,” said Sen. Ron Wyden of Oregon, the top Democrat on the Senate Finance Committee. “But I don’t see it as a comprehensive health insurance opportunity.”

Who Can Use HSAs?

The IRS sets restrictions on the use of HSAs, which are typically managed by banks or health insurance companies. For starters, on the ACA marketplace, they are available only to those with the highest-deductible health insurance plans — the bronze and catastrophic plans.

There are limits on how much can be deposited into an account each year. In 2026 it will be $4,400 for a single person and $8,750 for a family.

Flexible spending accounts, or FSAs — which are typically offered through employer coverage — work similarly but have lower savings limits and cannot be rolled over from year to year.

The law that established HSAs prohibits the accounts from being used to pay insurance premiums, meaning that without an overhaul, the GOP’s proposals are unlikely to alleviate the problem at hand: skyrocketing premium payments. Obamacare enrollees who receive subsidies are projected to pay 114% more out-of-pocket for their premiums next year on average, absent congressional action.

Even with the promise of the government depositing cash into an HSA, people may still opt to go without coverage next year once they see those premium costs, said Tom Buchmueller, an economics professor at the University of Michigan who worked in the Biden administration.

“For people who stay in the marketplace, they’re going to be paying a lot more money every month,” he said. “It doesn’t help them pay that monthly premium.”

Others, Buchmueller noted, might be pushed into skimpier insurance coverage. Obamacare bronze plans come with the highest out-of-pocket costs.

An HHS Official’s Interest

Health savings accounts can be used to pay for many routine medical supplies and services, such as medical and dental exams, as well as emergency room visits. In recent years, the government has expanded the list of applicable purchases to include over-the-counter products such as Tylenol and tampons.

Purchases for “general health” are not permissible, such as fees for dance or swim lessons. Food, gym memberships, or supplements are not allowed unless prescribed by a doctor for a medical condition or need.

Americans are investing more into these accounts as their insurance deductibles rise, according to Morningstar. The investment research firm found that assets in HSAs grew from $5 billion 20 years ago to $146 billion last year. President George W. Bush signed the law establishing health savings accounts in 2003, with the White House promising at the time that they would “help more American families get the health care they need at a price they can afford.”

Since then, the accounts have become most common for wealthier, white Americans who are healthy and have employer-sponsored health insurance, according to a report released by the nonpartisan Government Accountability Office in September.

Now, even more money is expected to flow into these accounts, because of the One Big Beautiful Bill Act. Companies are taking notice of the growing market for HSA-approved products, with major retailers such as Amazon, Walmart, and Target developing online storefronts dedicated to devices, medications, and supplies eligible to be purchased with money in the accounts.

Startups have popped up in recent years dedicated to helping people get quick approval from medical providers for various — and sometimes expensive — items, memberships, or fitness or health services.

Truemed — a company co-founded in 2022 by Calley Means, a close ally of Health and Human Services Secretary Robert F. Kennedy Jr. — has emerged as one of the biggest players in this niche space.

A $9,000 red cedar ice bath and a $2,000 hemlock sauna, for example, are available for purchase with HSA funds through Truemed. So, too, is the $1,700 bassinet, designed to automatically respond to the cries of a newborn by gently rocking the baby back to sleep.

Truemed’s executives say its most popular products are its smaller-dollar fitness offerings, which include kettlebells, supplements, treadmills, and gym memberships.

“What we’ve seen at Truemed is that, when given the choice, Americans choose to invest their health care dollars in these kinds of proven lifestyle interventions,” Truemed CEO Justin Mares told KFF Health News.

Means joined the Department of Health and Human Services in November after a stint earlier this year at the White House, where he worked when Trump signed the One Big Beautiful Bill Act into law in July. Truemed’s general counsel, Joe Vladeck, said Means left the company in August.

Asked about Means’ potential to benefit from the law’s expansion of HSAs, HHS spokeswoman Emily Hilliard said in a statement that “Calley Means will not personally benefit financially from this proposal as he will be divesting from his company since he has been hired at HHS as a senior advisor supporting food and nutrition policy.”

Truemed is privately held, not publicly traded, and details of how Means will go about divesting have not been disclosed.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.



Source link

Continue Reading

Business

Netflix lines up $59 billion of debt for Warner Bros. deal

Published

on



Netflix Inc. has lined up $59 billion of financing from Wall Street banks to help support its planned acquisition of Warner Bros. Discovery Inc., which would make it one of the largest ever loans of its kind.

Wells Fargo & Co., BNP Paribas SA and HSBC Plc are providing the unsecured bridge loan, according to a statement Friday, a type of financing that is typically replaced with more permanent debt such as corporate bonds.

Under the deal announced Friday, Warner Bros. shareholders will receive $27.75 a share in cash and stock in Netflix. The total equity value of the deal is $72 billion, while the enterprise value of the deal is about $82.7 billion.

Bridge loans are a crucial step for banks in building relationships with companies to win higher-paying mandates down the road. 

A loan of $59 billion would rank among the biggest of its type, Anheuser-Busch InBev SA obtained $75 billion of loans to back its acquisition of SABMiller Plc in 2015, the largest ever bridge financing, according to data compiled by Bloomberg.



Source link

Continue Reading

Business

Stocks: Facing a vast wave of incoming liquidity, the S&P 500 prepares to surf to a new record high

Published

on



The S&P 500 index ticked up 0.3% yesterday, its eighth straight upward trading session. It is now less than half a percentage point away from its record high, and futures were pointing marginally up again this morning. Nasdaq 100 futures were even more optimistic, up 0.39% before the open in New York. The VIX “fear” index (which measures volatility) has sunk 12.6% this month, indicating that investors seem to have settled in for a calm, quiet, risk-on holiday season.

They have reason to be happy. Washington is preparing a wave of incoming liquidity that is likely to generate fresh demand for equities.

For instance, the CME FedWatch index shows an 87% chance that the U.S. Federal Reserve will deliver an interest rate cut next week, delivering a new round of cheaper money. Further cuts are expected in 2026.

Furthermore, Wall Street largely expects President Trump to announce that Kevin Hassett will replace Fed chairman Jerome Powell in May—and Hassett is widely regarded as a dove who will lean in favor of further rate cuts.

Elsewhere, the Fed has begun a series of “reserve management purchases,” a program in which the central bank will buy short-term T-bills—a move that will add more liquidity to markets generally.

Banks, brokers and trading platforms are also lining up to handle ‘Trump Accounts,’ into which the U.S. government will deposit $1,000 for every child. The trust fund can be invested in low-cost stock index trackers—a new source of investment demand coming online in the back half of 2026.

So it’s no surprise that nine major investment banks polled by the Financial Times expect stocks to rise in 2026; the average of their estimates is by 10%.

The Congressional Budget Office also estimates that the One Big Beautiful Bill Act will add 0.9% to U.S. GDP next year largely because it allows companies to immediately deduct capital expenditures from their taxes—spurring a huge round of corporate spending. 

With all that fresh money on the horizon, it’s clear why markets have shrugged off their worries about AI and Bitcoin. The only shock will be if the S&P fails to hit a new all-time high by the end of the year.

Here’s a snapshot of the markets ahead of the opening bell in New York this morning:

  • S&P 500 futures were up 0.2% this morning. The last session closed up 0.3%. 
  • STOXX Europe 600 was up 0.3% in early trading. 
  • The U.K.’s FTSE 100 was up 0.14% in early trading. 
  • Japan’s Nikkei 225 was up 2.33%. 
  • China’s CSI 300 was up 0.34%. 
  • The South Korea KOSPI was down 0.19%. 
  • India’s NIFTY 50 is up 0.18%. 
  • Bitcoin was flat at $93K.



Source link

Continue Reading

Trending

Copyright © Miami Select.